ObjectiveThis annual conference aims at keeping legal practitioners working with the pharmaceutical sector up-to-date on the latest relevant regulatory developments, legislative initiatives and case law. A particular focus will be on implications for the sector of recent EU activities in the fields of competition law, intellectual property, as well as pharmaceutical law.Key topicsCompetition lawThe revised competition and licensing regime for technology transfer agreementsReverse patent settlements and impact of the recent decision from the European Commission in Servier     Actions for damages Patent law and trade secretsPreparing  for litigation before the future Unified Patent Court  Unitary patent and supplementary protection certificates: is the current legal framework still adequate?A new enforcement regime for trade secretsEU pharmaceutical law round-upUpdate on medical devices and in-vitro diagnosticsThe revised transparency policy adopted by the EMA towards access to clinical trials dataInnovative pricing and reimbursement modelsNational and EU current policies towards access to medicinal products: off-label use, orphan drugs, national measures against drugs shortageImplications of the Transatlantic Trade and Investment PartnershipWho should attend?In-house counsel and legal or patent advisers in pharmaceutical companies; lawyers in private practice dealing with pharmaceuticals and medical devices; lawyers in national ministries and authorities dealing with regulation of the sector.